Skip to main content
OpenTrials

Clinical trial condition

Recurrent Hairy Cell Leukemia

Explore clinical trials studying Recurrent Hairy Cell Leukemia. Study availability and eligibility vary by location and protocol.

7 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Hairy Cell Leukemia trial results

Recruiting

Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia

NCT06311227

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • UM Sylvester Comprehensive Cancer Center at Aventura Aventura, Florida, United States
  • UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables, Florida, United States
View all 21 locations
View Trial Details
Recruiting

Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell Leukemia

NCT06965114

Conditions
Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • NCI - Center for Cancer Research Bethesda, Maryland, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
  • University of Virginia Cancer Center Charlottesville, Virginia, United States
View Trial Details
Active, Not Recruiting

Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia

NCT01841723

Conditions
Hairy Cell Leukemia, Hairy Cell Leukemia Variant, Hematologic Diseases, +11 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia

NCT02153580

Conditions
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma, B-Cell Prolymphocytic Leukemia, Burkitt Lymphoma, +43 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View Trial Details

Related conditions